Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains
- 13 July 2001
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 310 (3), 591-601
- https://doi.org/10.1006/jmbi.2001.4703
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Negative regulation of T cell activationCurrent Opinion in Immunology, 1998
- CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast KineticsThe Journal of Experimental Medicine, 1997
- Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model.JCI Insight, 1996
- Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory InteractionsJournal of Biological Chemistry, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991